Skip to main content
. 2019 Mar 7;2019:2835152. doi: 10.1155/2019/2835152

Figure 2.

Figure 2

Showing the level of MDA, GSH, CAT, and SOD and plasma inflammatory markers of the indicated groups after the treatment. All the data has been expressed as mean ± SEM of eight independent samples from each group (n = 8) analyzed by SPSS 13.0 version. : statistical difference from the normal control (CN or group I). #: statistical difference from the positive control group (diabetic: DM or group II). DM+E200: diabetic rats treated with 200mg/Kg of leaf extract (group III); DM+E400: diabetic rats treated with 400mg/Kg of leaf extract; DM+GBC (group IV): diabetic rats treated with glibenclamide (group V).